Studies Currently Recruiting |
Name of Study | Study Type | Duration |
ADNI 2
Alzheimer's Disease Neuroimaging Initiative 2 | Memory | 4.5 years |
ASPREE
Aspirin in Reducing Events in the Elderly | Cardiovascular/Memory/Aspirin | 5 years |
CLIP II
Cooperative Lifestyle Intervention Program II at the | Physical Activity/Weight Loss | 18 months |
INFINITE
Investigating Fitness Interventions in the Elderly | Physical Activity/Weight Loss | 5 months |
PACE
Program for Active Aging and Community Engagement | Physical Activity/Healthy Aging | 12 months |
START
Strength Training for ARthritis Trial | Physical Activity/Healthy Aging | 18 months |
Ongoing Studies |
ACCORDION
Action to Control Cardiovascular Risk in Diabetes (ACCORD) Followp-Up Study |
ACCORDION MIND
Action to Control Cardiovascular Risk in Diabetes (ACCORD) Follow-Up Study – Memory in Diabetes Follow-Up Study |
ADNI-GO
Alzheimer’s Disease Neuroimaging Initiative Grand Opportunity |
ASPREE HUB
Aspirin in Reducing Events in the Elderly |
BMS
BMSA Multicenter, Randomized Double-Blind Placebo-Controlled Study of the safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients with Prodromal Alzheimer's Disease |
I’M FIT
Improving Muscle for Functional Independence |
JDDJ - Eli Lilly
A Phase 2 Randomized Study to Investigate the Efficacy and Safety of LY2495655 Versus Placebo in Older Patients Who Have Fallen Recently and Have Muscle Weakness |
LIFE Cognition
Lifestyle Interventions and Independence for Elders Cognitive Sub Study |
LIFE Study
Lifestyle Interventions and Independence for Elders |
Look AHEAD Ancillary Study
Ancillary Study Intentional Weight Reduction and Physical and Cognitive Function |
PREDICT
Vascular Stiffness and Pulmonary Congestion |
SPRINT
Systolic Blood Pressure Intervention Trial |
SPRINT MIND
The SPRINT Memory and Cognition IN Decreased hypertension |
Completed Studies |
ACCORD
Action to Control Cardiovascular Risk in Diabetes |
ACCORD MIND
Action to Control Cardiovascular Risk in Diabetes – Memory in Diabetes |
ADAPT
Arthritis, Diet, and Activity Promotion Trial |
ADNI
Alzheimer's Disease Neuroimaging Initiative |
AIM HIGH
Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglyceride and Impact on Global Health Outcomes |
AVID
AV-45-A11 |
DEMO
Diet, Exercise and Metabolism in Older Women |
DHA
A Randomized Double-Blind Placebo-Controlled Trial of the Effects of Docosahexaenoic Acid (DHA) in Slowing the Progression of Alzheimer's Disease |
DHS MIND
Genetics of Cerebrovascular Disease and Cognitive Impairment in the Diabetes Heart Study |
GEM
Ginkgo Evaluation of Memory |
GENE
GENE POLYMORPHISMS |
HBA
Multi-Center Trial to Evaluate Home-Based Assessment Methods for Alzheimer Disease Prevention Research in People Over 75 Years Old |
ICARA
A Phase III, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Efficacy and Safety Trial of Bapineuzumab (AAB-001, ELN115727) In Patients With Mild to Moderate Alzheimer's Disease Who Are Apolipoprotein E4 Non-Carriers (301) or Carriers (302) |
IDENTITY
Effect of γ-Secretase Inhibition on the Progression of Alzheimer’s Disease: LY450139 versus Placebo |
LIFE – Pilot Study
Lifestyle Interventions and Independence for Elders |
MY BUDDY STUDY
Community-Based, Buddy-Supported Exercise in Patients with MCI |
OPTIMA
Optimizing Body Composition in Older Adults |
PIE 2
Pharmacological Intervention in the Elderly Phase 2 |
REACT 3
Strength training and ACE I/D genotype in patients with chronic obstructive pulmonary disease |
S-CONNECT
A Randomized Controlled Trial to Assess the Efficacy of a Medical Food in Patients with Mild to Moderate Alzheimer’s Disease using Alzheimer’s Disease Medication |
SECRET
Study of the Effects of Caloric Restriction and Exercise Training |
VITAMIN D
Vitamin D, Falls, Fractures and Function in Community-dwelling Older Adults |